FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) Fexofenadine Hydrochloride Tablets Recall

Fexofenadine Hydrochloride Tablets, USP 60 mg, Allergy, Non-Drowsy, Antihistamine, 100…

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · Rockford, IL

Risk level
Class III
Reported by FDA
May 27, 2015
Recall ID
D-1083-2015
Check your lot numberHow we source this data

Summary

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalled Fexofenadine Hydrochloride Tablets starting Mar 26, 2015. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1083-2015 on May 27, 2015. Reason: Failed Impurities/Degradation Specifications: the manufacturer, recalled product due to slightly above specification results for a Related Compound during routine stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: the manufacturer, recalled product due to slightly above specification results for a Related Compound during routine stability testing

Product description

Fexofenadine Hydrochloride Tablets, USP 60 mg, Allergy, Non-Drowsy, Antihistamine, 100 tablets (10 X 10) per UD Cartons, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, USA, NDC 51079-547-20

Lot numbers, UPCs & expiration codes

Lot #: 3051728, 3053762, Exp. 4/2015

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1083-2015
Classification
Class III
Status
Terminated
Recall initiated
Mar 26, 2015
FDA report date
May 27, 2015
Quantity
1,363 UD Cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Original FDA data

Every field from FDA enforcement report D-1083-2015, exactly as published.

Show all FDA fields
City
Rockford
State
IL
Status
Terminated
Country
United States
Event ID
70857
Address
1718 Northrock Ct
Code information
Lot #: 3051728, 3053762, Exp. 4/2015
Postal code
61103-1201
Report date
May 27, 2015
Product type
Drugs
Recall number
D-1083-2015
Classification
Class III
Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Product quantity
1,363 UD Cartons
Termination date
Aug 31, 2015
Reason for recall
Failed Impurities/Degradation Specifications: the manufacturer, recalled product due to slightly above specification results for a Related Compound during routine stability testing
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fexofenadine Hydrochloride Tablets, USP 60 mg, Allergy, Non-Drowsy, Antihistamine, 100 tablets (10 X 10) per UD Cartons, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, USA, NDC 51079-547-20
Distribution pattern
Nationwide
Recall initiation date
Mar 26, 2015
Initial firm notification
Letter
Center classification date
May 15, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1083-2015, published May 27, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls